CoChat

Interactions of Human Melanocortin 4 Receptor with Nonpeptide and Peptide Agonists,

Open access

The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.

Abstract

Specific interactions of human melanocortin-4 receptor (hMC4R) with its nonpeptide and peptide agonists were studied using alanine-scanning mutagenesis. The binding affinities and potencies of two synthetic, small-molecule agonists (THIQ, MB243) were strongly affected by substitutions in transmembrane alpha-helices (TM) 2, 3, 6, and 7 (residues Glu(100), Asp(122), Asp(126), Phe(261), His(264), Leu(265), and Leu(288)). In addition, a I129A mutation primarily affected the binding and potency of THIQ, while F262A, W258A, Y268A mutations impaired interactions with MB243. By contrast, binding affinity and potency of the linear peptide agonist NDP-MSH were substantially reduced only in D126A and H264A mutants. Three-dimensional models of receptor-ligand complexes with their agonists were generated by distance-geometry using the experimental, homology-based, and other structural constraints, including interhelical H-bonds and two disulfide bridges (Cys(40)-Cys(279), Cys(271)-Cys(277)) of hMC4R. In the models, all pharmacophore elements of small-molecule agonists are spatially overlapped with the corresponding key residues (His(6), d-Phe(7), Arg(8), and Trp(9)) of the linear peptide: their charged amine groups interact with acidic residues from TM2 and TM3, similar to His(6) and Arg(6) of NDP-MSH; their substituted piperidines mimic Trp(9) of the peptide and interact with TM5 and TM6, while the d-Phe aromatic rings of all three agonists contact with Leu(133), Trp(258), and Phe(261) residues.

Overview

Integrity signals

Registry

Crossref · 10.1021/bi0501840

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Research works printed but not linked: 44

  1. Wikberg J. E., 2000, Pharmacol. Res. 42, 393−420.
  2. Haqq A. M., 2003, Biochem. J., 376
  3. Van der Ploeg L. H., 2002, Proc. Natl. Acad. Sci. U.S.A. 99
  4. Yeo G. S., 2003, Hum. Mol. Genet. 12, 561−574.
  5. Tao Y. X., 2003, Endocrinology 144, 4544−4551.
  6. Nijenhuis W. A., 2001, Mol. Endocrinol. 15, 164−171.
  7. Chai B. X., 2003, Peptides 24, 603−609.
  8. Palucki B. L., 2005, Bioorg. Med. Chem. Lett., 15
  9. Wisse B. E., 2003, Ann. N.Y. Acad. Sci. 994, 275−281.
  10. Willoughby C. A., 2002, Bioorg. Med. Chem. Lett., 12, 96
  11. Palczewski K., 2000, Science 289, 739−745.
  12. Li J., 2004, J. Mol. Biol., 343
  13. John B., 2003, Nucleic Acids Res. 31, 3982−3992.
  14. Farrens D. L., 1996, Science 274, 768−770.
  15. Halperin I., 2002, Proteins 47, 409−443.
  16. Pogozheva I. D., 1997, Biophys. J. 72
  17. Fowler C., 2004, Biochemistry 43, 8700−8710.
  18. Fowler C. B., 2004, Biochemistry 43, 15796−15810.
  19. Chai B.-X., 2005, Biochemistry 44, 3418−3431.
  20. Meng E. C., 2001, Trends Pharmacol. Sci. 22, 587−593.
  21. Karnik S. S., 2003, Trends Endocrinol. Metab. 14, 431−437.
  22. Hadley M. E., 1981, Science 213, 1025−1027.
  23. Yang Y.-K., 2000, Biochemistry 39, 14900−14911.
  24. Yang Y.-K., 1997, J. Biol. Chem., 272
  25. DeBlasi A., 1989, Trends Pharmacol. Sci. 10, 227−229.
  26. Sawyer T. K., 1982, Proc. Natl. Acad. Sci. U.S.A. 79
  27. Obeidi F., 1989, J. Am. Chem. Soc., 111
  28. Haskell-Luevano C., 1997, J. Med. Chem., 40
  29. Sawyer T. K., 1980, Proc. Natl. Acad. Sci. U.S.A. 77
  30. Prusis P., 1995, Biochem. Biophys. Res. Commun. 210, 205−210.
  31. Hruby V. J., 1995, J. Med. Chem., 38
  32. Nikiforovich G. V., 1998, Biopolymers 46, 155−167.
  33. Ying J., 2003, Biopolymers 71, 696−716.
  34. Cai M., 2004, J. Pept. Res., 63
  35. Kask A., 1998, Endocrinology 139, 5006−5014.
  36. Sugg E. E., 1988, Biochemistry 27, 8181−8188.
  37. Haskell-Luevano C., 2000, Peptides, 21, 57
  38. Nijenhuis W. A., 2003, Peptides 24, 271−280.
  39. Yang Y., 2002, J. Biol. Chem., 277
  40. Holder J. R., 2002, J. Med. Chem., 45
  41. Herpin T. F., 2003, Chem. 46, 1123−1126.
  42. Pan K., 2003, Chem. 11, 185−192.
  43. Richardson T. I., 2004, J. Med. Chem, 47
  44. Ballesteros J. A., 1995, Methods Neurosci. 25, 366−428.

Cited by

See all 97

Metadata

Authors
Pogozheva, I. D., Chai, B.-X., Lomize, A. L., Fong, T. M., Weinberg, D. H., Nargund, R. P., Mulholland, M. W., Gantz, I., & Mosberg, H. I.
Affiliations
Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
Venue
Biochemistry
Published
2005-08-01
Volume
44
Issue
34
Pages
11329-11341
ISSN
  • 0006-2960 (ISSN-L)
  • 1520-4995
OpenAlex
W1995624852
Cited by
92
References
81
Citations by year
2024: 2 · 2023: 2 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 2 · 2017: 8 · 2016: 4 · 2015: 4 · 2014: 7 · 2013: 7 · 2012: 7
FWCI
2.77
Type
journal article
Language
en
Open access
Locations
  • Biochemistry (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • University of Michigan
  • National Institute on Drug Abuse (R01DA003910, DA03910)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034933, P30 DK 34933, R01DK054032, DK054032)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
melanocortin-4 receptor, ligand-receptor interactions, peptide agonists, NDP-MSH, alanine scanning, transmembrane helices, disulfide bonds, pharmacophore, binding affinity, agonist potency
MeSH terms
Cyclic AMP, Amino Acid Sequence, Binding Sites, Humans, Models, Molecular, Molecular Sequence Data, Peptides, Piperazines, Piperidines, Recombinant Proteins, Rhodopsin, Transfection, Mutagenesis, Site-Directed, Sequence Alignment, Sequence Homology, Amino Acid, Protein Structure, Secondary, Receptor, Melanocortin, Type 4

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.